602
Views
4
CrossRef citations to date
0
Altmetric
Neurotherapeutics

The impact of antidepressant treatments on family functioning in adults with major depressive disorder: a post hoc comparison of vortioxetine and agomelatine

, , , &
Pages 1057-1066 | Received 29 Aug 2016, Accepted 20 Feb 2017, Published online: 28 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Trevor R. Norman & James S. Olver. (2019) Agomelatine for depression: expanding the horizons?. Expert Opinion on Pharmacotherapy 20:6, pages 647-656.
Read now
Xenia Gonda, Samata R. Sharma & Frank I. Tarazi. (2019) Vortioxetine: a novel antidepressant for the treatment of major depressive disorder. Expert Opinion on Drug Discovery 14:1, pages 81-89.
Read now

Articles from other publishers (2)

Michael Adair, Michael Cronquist Christensen, Ioana Florea, Henrik Loft & Andrea Fagiolini. (2023) Vortioxetine in patients with major depressive disorder and high levels of anxiety symptoms: An updated analysis of efficacy and tolerability. Journal of Affective Disorders 328, pages 345-354.
Crossref
Lone Baandrup, Jesper Østrup Rasmussen, Jan Mainz, Poul Videbech & Solvejg Kristensen. (2022) Patient-reported outcome measures in mental health clinical research: a descriptive review in comparison with clinician-rated outcome measures. International Journal for Quality in Health Care 34:Supplement_1, pages ii70-ii97.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.